3136 results for «2781»

Filter By

3136 results

Chronic coronary syndrome with low ejection fraction and left ventricle support

21 May 2025 – From EuroPCR 2025

This session examines the management of chronic coronary syndrome in patients with low ejection fraction, emphasizing the role of left ventricular support. Topics include risks of intracoronary imaging, pharmacological facilitation, mechanical circulatory support, and alternatives like LAVA-ECMO.

Chronic coronary syndrome with low ejection fraction and left ventricle support

How to deal with left main culprit in NSTEMI

21 May 2025 – From EuroPCR 2025

This session offers a cross-geographic exchange on managing left main culprit lesions in NSTEMI patients. Learn different interventional approaches, risk evaluation for periprocedural complications, and diverse PCI management strategies tailored to this complex subgroup.

How to deal with left main culprit in NSTEMI

Right ventricule and tricuspid regurgitation: a linked faith

21 May 2025 – From EuroPCR 2025

Investigate the interconnected pathophysiology of right ventricular function and tricuspid regurgitation. This session reviews predictors of outcomes post-transcatheter tricuspid valve repair, the impact of disproportionate regurgitation, and changes in ventricular contraction patterns.

Right ventricule and tricuspid regurgitation: a linked faith

Coronary dissection : when imaging makes the difference

21 May 2025 – From EuroPCR 2025

Explore the critical role of intracoronary imaging in diagnosing and managing coronary dissections and related complications. Through case studies, learn about bailout strategies and the domino effect of decisions during PCI in acute myocardial infarction.

Coronary dissection : when imaging makes the difference

Therapeutic choices for TTVIV-TTVIR interventions

21 May 2025 – From EuroPCR 2025

Explore therapeutic choices for transcatheter tricuspid valve-in-valve and valve-in-ring interventions. Case studies cover annular ring expansion, pacing-related infection, jugular vein access valve replacement, Ebstein anomaly, and double valve-in-valve procedures in right heart disease.

Therapeutic choices for TTVIV-TTVIR interventions

Calcium modification: contemporary comparaisons of atherectomy and IVL

22 May 2025 – From EuroPCR 2025

Compare contemporary calcium modification techniques including atherectomy and intravascular lithotripsy (IVL) in complex coronary lesions. Review clinical outcomes, procedural case studies, and registry data highlighting safety and efficacy in acute coronary syndrome and high-risk patients.

Calcium modification: contemporary comparaisons of atherectomy and IVL

Mitral TEER in challenging scenarios - Part 3

21 May 2025 – From EuroPCR 2025

This session focuses on challenging mitral TEER cases, including papillary muscle rupture post-myocardial infarction, advanced heart failure treatment, emerging therapies for mitral regurgitation, and novel percutaneous repair techniques.

Mitral TEER in challenging scenarios - Part 3

Complications in STEMI : dissections and more

21 May 2025 – From EuroPCR 2025

Address complications encountered in STEMI interventions such as dissections and coronary perforations. Learn from case presentations highlighting procedural challenges, management of delayed perforations, and balancing procedural perfection with practical outcomes.

Complications in STEMI : dissections and more

Hotline TAVI 3: Challenging anatomical and clinical scenarios

22 May 2025 – From EuroPCR 2025

This hotline session presents challenging anatomical and clinical scenarios in TAVI, including outcomes in bicuspid aortic valve patients, chronic aortic regurgigation, comparisons of surgical versus percutaneous approaches, and real-world data on valve performance and resource utilization.

Inludes:

  • Five-year outcomes from the Evolut low risk TAVR bicuspid study
  • Surgical versus...
Hotline TAVI 3: Challenging anatomical and clinical scenarios

OHCM, ablation complications: interventional solutions

21 May 2025 – From EuroPCR 2025

Explore interventional solutions for complications arising in obstructive hypertrophic cardiomyopathy (OHCM) and ablation procedures. Cases include complex congenital anomalies, novel non-invasive treatments, dual pulmonary vein stenosis, iatrogenic fistulas, and ablation-related cardiac defects.

OHCM, ablation complications: interventional solutions

Outcome prediction using artificial intelligence and meta-analysis

22 May 2025 – From EuroPCR 2025

This session presents outcome prediction advancements through artificial intelligence and meta-analysis in cardiology. Topics include AI-guided aortic stenosis risk stratification, predictors of periprocedural stroke after TAVI, patient-specific computer simulations for bicuspid TAVI, and enhancements in large language model accuracy using Heart Team simulation.

Outcome prediction using artificial intelligence and meta-analysis

Antiplatelet strategies for patients undergoing PCI

22 May 2025 – From EuroPCR 2025

Delve into this comprehensive session focusing on antiplatelet strategies for patients undergoing PCI. Explore evidence and clinical insights on ticagrelor monotherapy post-AMI stenting, shortened dual antiplatelet therapy (DAPT) durations, the role of CYP2C19 genotyping in stent thrombosis risk, the effectiveness of dual antithrombotic therapy in atrial...

Antiplatelet strategies for patients undergoing PCI

Radiation protection: the good and the bad

22 May 2025 – From EuroPCR 2025

This session provides essential guidance on radiation protection in the cath lab. Learn practical steps to minimize radiation exposure for yourself and your team, manage the ergonomic challenges of protective gear, and develop skills to foster a culture of radiation safety within your workplace. Understand the...

Radiation protection: the good and the bad

Imaging makes it clear!

22 May 2025 – From EuroPCR 2025

Explore the critical role of intravascular imaging in interventional cardiology through real-world cases. This session highlights the value of intravascular ultrasound (IVUS) in avoiding unnecessary stenting in STEMI patients, the application of optical coherence tomography (OCT) in complex scenarios, and the management of calcified lesions with...

Imaging makes it clear!

Managing ischaemic and bleeding risk of NSTEMI patients

22 May 2025 – From EuroPCR 2025

Gain valuable insights into managing ischemic and bleeding risks in NSTEMI patients. This session reviews optimal timing for invasive strategies, variability in care processes, radial access approaches, and innovative antithrombotic strategies such as aspirin omission and prasugrel monotherapy to minimize bleeding while optimizing outcomes.

Managing ischaemic and bleeding risk of NSTEMI patients

Patients with degenerated aortic bioprothesis - Every case is different

22 May 2025 – From EuroPCR 2025

Delve into the nuanced management of patients with degenerated aortic bioprostheses, emphasizing that no two cases are alike. This session provides expert insights into selecting optimal valve-in-valve TAVI approaches tailored to individual anatomy and clinical context. Learn practical strategies to overcome complex challenges such as coronary...

Patients with degenerated aortic bioprothesis - Every case is different

Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?

22 May 2025 – From EuroPCR 2025

Explore the evolving landscape of catheter-directed therapy for intermediate-high and high-risk pulmonary embolism. This session covers patient selection criteria, clinical signs indicating the need for intervention, management of potential complications, and ongoing studies shaping future treatments. Case-based discussions illustrate practical applications and key learnings.

Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?

New frontier in renal denervation: data, devices and developments

22 May 2025 – From EuroPCR 2025

Advance your understanding of renal denervation with the latest data, innovative devices, and emerging developments. This session reviews the 12-month results of the REDUCED 1 trial evaluating the TIVUS system, explores safety and efficacy of novel renal stimulation techniques, and presents outcomes from registries including patients...

New frontier in renal denervation: data, devices and developments

Challenges and risks of percutaneous treatment of calcified lesions

22 May 2025 – From EuroPCR 2025

Learn how to effectively manage calcified coronary lesions and their associated risks in this focused session. Understand the critical role of plaque modification and intravascular imaging, and gain insights into addressing stent thrombosis following interventions on calcified lesions through detailed case analyses.

Challenges and risks of percutaneous treatment of calcified lesions

Advancing knowledge and innovations in peripheral interventions

22 May 2025 – From EuroPCR 2025

Expand your expertise in peripheral interventions with a focus on recent innovations and clinical insights. This session covers pre-clinical results of a novel Hybrid Drug-Eluting Stent for below-the-knee arteries, the prognostic impact of proteinuria in LEAD patients with chronic kidney disease, beta-blocker therapy effects post-frozen elephant...

Advancing knowledge and innovations in peripheral interventions
Didn’t find what you were looking for?